ELV Elevance Health Inc

Price (delayed)

$525.19

Market cap

$122.06B

P/E Ratio

19.71

Dividend/share

$6.07

EPS

$26.64

Enterprise value

$142.29B

Anthem is a leading health benefits company dedicated to improving lives and communities, and making healthcare simpler. Through its affiliated companies, Anthem serves more than 110 million people, including approximately ...

Highlights
The equity has increased by 9% YoY and by 3.3% from the previous quarter
ELV's gross profit is up by 8% year-on-year
ELV's P/E is 14% above its 5-year quarterly average of 17.3 and 10% above its last 4 quarters average of 18.0
ELV's quick ratio is down by 6% year-on-year and by 5% since the previous quarter

Key stats

What are the main financial stats of ELV
Market
Shares outstanding
232.42M
Market cap
$122.06B
Enterprise value
$142.29B
Valuations
Price to book (P/B)
3.01
Price to sales (P/S)
0.71
EV/EBIT
15.66
EV/EBITDA
13.3
EV/Sales
0.83
Earnings
Revenue
$171.75B
EBIT
$9.09B
EBITDA
$10.7B
Free cash flow
$2.3B
Per share
EPS
$26.64
Free cash flow per share
$9.87
Book value per share
$174.53
Revenue per share
$738.15
TBVPS
$323.37
Balance sheet
Total assets
$111.89B
Total liabilities
$71.18B
Debt
$26.45B
Equity
$40.61B
Working capital
$16.61B
Liquidity
Debt to equity
0.65
Current ratio
1.37
Quick ratio
1.23
Net debt/EBITDA
1.89
Margins
EBITDA margin
6.2%
Gross margin
17.5%
Net margin
3.6%
Operating margin
5.3%
Efficiency
Return on assets
5.7%
Return on equity
16%
Return on invested capital
18.8%
Return on capital employed
13.5%
Return on sales
5.3%
Dividend
Dividend yield
1.16%
DPS
$6.07
Payout ratio
22.8%

ELV stock price

How has the Elevance Health stock price performed over time
Intraday
3.19%
1 week
4.63%
1 month
2.72%
1 year
8.72%
YTD
11.37%
QTD
1.28%

Financial performance

How have Elevance Health's revenue and profit performed over time
Revenue
$171.75B
Gross profit
$30.02B
Operating income
$9.08B
Net income
$6.24B
Gross margin
17.5%
Net margin
3.6%
ELV's gross profit is up by 8% year-on-year
The company's revenue rose by 7% YoY
Elevance Health's net margin has decreased by 5% YoY but it has increased by 2.9% from the previous quarter
Elevance Health's net income has increased by 4.3% QoQ and by 2.5% YoY

Growth

What is Elevance Health's growth rate over time

Valuation

What is Elevance Health stock price valuation
P/E
19.71
P/B
3.01
P/S
0.71
EV/EBIT
15.66
EV/EBITDA
13.3
EV/Sales
0.83
ELV's P/E is 14% above its 5-year quarterly average of 17.3 and 10% above its last 4 quarters average of 18.0
Elevance Health's EPS has increased by 5% QoQ and by 4.4% YoY
ELV's price to book (P/B) is 16% higher than its 5-year quarterly average of 2.6 and 8% higher than its last 4 quarters average of 2.8
The equity has increased by 9% YoY and by 3.3% from the previous quarter
The company's revenue rose by 7% YoY

Efficiency

How efficient is Elevance Health business performance
Elevance Health's ROIC has decreased by 6% YoY
ELV's ROE is down by 4.8% YoY but it is up by 2.6% QoQ
Elevance Health's return on assets has increased by 3.6% QoQ but it has decreased by 3.4% YoY
Elevance Health's return on sales has increased by 3.9% QoQ but it has decreased by 3.6% YoY

Dividends

What is ELV's dividend history
DPS
$6.07
Dividend yield
1.16%
Payout ratio
22.8%
Recent dividends

Financial health

How did Elevance Health financials performed over time
The total assets is 57% higher than the total liabilities
ELV's quick ratio is down by 6% year-on-year and by 5% since the previous quarter
The current ratio fell by 4.9% QoQ and by 4.2% YoY
Elevance Health's debt is 35% less than its equity
The equity has increased by 9% YoY and by 3.3% from the previous quarter
Elevance Health's debt has increased by 5% from the previous quarter and by 3.9% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.